NCT01780753View on ClinicalTrials.gov

Primaquine Pharmacokinetics in Lactating Women and Their Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2014

Conditions
Vivax Malaria
Interventions
DRUG

Primaquine

Primaquine GPO® (Government Pharmaceutical Organization, Thailand) 0.5 mg/kg will be given once daily for 14 days.

Trial Locations (1)

Unknown

Shoklo Malaria Research Unit, Mae Sot

All Listed Sponsors
lead

University of Oxford

OTHER

NCT01780753 - Primaquine Pharmacokinetics in Lactating Women and Their Infants | Biotech Hunter | Biotech Hunter